| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
| 2 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 3 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma | Blood | 2008 | 819 |
| 4 | Double-hit B-cell lymphomas | Blood | 2011 | 603 |
| 5 | Treatment of Older Patients with Mantle-Cell Lymphoma | New England Journal of Medicine | 2012 | 465 |
| 6 | Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology | Journal of Allergy and Clinical Immunology | 2016 | 289 |
| 7 | Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study | Blood | 2010 | 243 |
| 8 | KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis | Leukemia | 2015 | 229 |
| 9 | Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future | Cancer Research | 2017 | 210 |
| 10 | Down-Regulation of E-Cadherin in Human Bronchial Epithelial Cells Leads to Epidermal Growth Factor Receptor-Dependent Th2 Cell-Promoting Activity | Journal of Immunology | 2007 | 149 |
| 11 | The multifaceted role of autophagy in cancer and the microenvironment | Medicinal Research Reviews | 2019 | 146 |
| 12 | Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma | Journal of Clinical Oncology | 2006 | 144 |
| 13 | The Role of Macrophages in Cancer Development and Therapy | Cancers | 2021 | 143 |
| 14 | Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial | Lancet Haematology,the | 2016 | 136 |
| 15 | Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2014 | 129 |
| 16 | Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis | Blood | 2009 | 127 |
| 17 | Therapeutic Drug Monitoring of Posaconazole: an Update | Current Fungal Infection Reports | 2016 | 126 |
| 18 | Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients | Blood | 2019 | 125 |
| 19 | Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials | Lancet Haematology,the | 2015 | 123 |
| 20 | Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes | Blood | 2008 | 114 |
| 21 | Voriconazole metabolism is influenced by severe inflammation: a prospective study | Journal of Antimicrobial Chemotherapy | 2017 | 113 |
| 22 | Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network | Blood | 2018 | 108 |
| 23 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts | Theranostics | 2020 | 107 |
| 24 | A Limited Role for p21Cip1/Waf1in Maintaining Normal Hematopoietic Stem Cell Functioning | Stem Cells | 2007 | 102 |
| 25 | International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study | Lancet Haematology,the | 2019 | 101 |
| 26 | Genomic alterations and gene expression in primary diffuse large B‐cell lymphomas of immune‐privileged sites: the importance of apoptosis and immunomodulatory pathways | Journal of Pathology | 2008 | 100 |
| 27 | Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal | Annals of Oncology | 2014 | 99 |
| 28 | Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1 | Blood | 2008 | 98 |
| 29 | Gonadal Function in Males After Chemotherapy for Early-Stage Hodgkin's Lymphoma Treated in Four Subsequent Trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Étude des Lymphomes de l'Adulte | Journal of Clinical Oncology | 2007 | 96 |
| 30 | Evaluation of 1025 fetal deaths: proposed diagnostic workup | American Journal of Obstetrics and Gynecology | 2012 | 92 |
| 31 | Epstein-Barr Virus???DNA Load Monitoring Late After Lung Transplantation: A Surrogate Marker of the Degree of Immunosuppression and a Safe Guide to Reduce Immunosuppression | Transplantation | 2007 | 87 |
| 32 | von Willebrand disease and aging: an evolving phenotype | Journal of Thrombosis and Haemostasis | 2014 | 87 |
| 33 | Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial | Clinical Cancer Research | 2020 | 86 |
| 34 | An Assessment of Clinical Interchangeability of TEG® and RoTEM® Thromboelastographic Variables in Cardiac Surgical Patients | Anesthesia and Analgesia | 2010 | 84 |
| 35 | HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? | OncoImmunology | 2017 | 84 |
| 36 | MEN2A-RET-induced cellular transformation by activation of STAT3 | Oncogene | 2001 | 82 |
| 37 | Innovations, challenges, and minimal information for standardization of humanized mice | EMBO Molecular Medicine | 2020 | 82 |
| 38 | Higher mast cell load decreases the risk of Hymenoptera venom–induced anaphylaxis in patients with mastocytosis | Journal of Allergy and Clinical Immunology | 2013 | 81 |
| 39 | Inflammation Is Associated with Voriconazole Trough Concentrations | Antimicrobial Agents and Chemotherapy | 2014 | 81 |
| 40 | Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials | Haematologica | 2009 | 80 |
| 41 | Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study | Journal of Clinical Oncology | 2021 | 80 |
| 42 | Fertility preservation after chemotherapy for Hodgkin lymphoma | Hematological Oncology | 2010 | 79 |
| 43 | Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial | Nature Medicine | 2021 | 79 |
| 44 | Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma | Modern Pathology | 2009 | 78 |
| 45 | Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy | Biochemical Pharmacology | 2010 | 78 |
| 46 | Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study | Journal of Rheumatology | 2011 | 78 |
| 47 | Prevalence of indolent systemic mastocytosis in a Dutch region | Journal of Allergy and Clinical Immunology | 2013 | 78 |
| 48 | Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | 2016 | 77 |
| 49 | Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels | Molecular and Cellular Biology | 2008 | 76 |
| 50 | Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis | Biology of Blood and Marrow Transplantation | 2016 | 76 |
